Top Industry Leaders in the Personalized Medicine Market
Latest Personalized Medicine Companies Update:
Illumina Acquired GRAIL, Inc., a leader in cancer early detection through circulating tumor DNA (ctDNA) testing, strengthening its portfolio and positioning itself for further growth in personalized oncology.
Roche Purchased Personalis, Inc., a company specializing in next-generation sequencing (NGS) and clinical data analytics, expanding its personalized medicine capabilities in various therapeutic areas
AstraZeneca Announced positive Phase 3 results for LYNPARZA® (olaparib) in BRCA1/2-mutated metastatic pancreatic cancer, demonstrating personalized treatment potential.
Foundation Medicine Received FDA approval for its FoundationOne CDx liquid biopsy assay, enabling comprehensive tumor profiling from blood samples for personalized treatment planning.
List of Personalized Medicine Key companies in the market
- Illumina Inc.
- Precision Biologics
- Danaher Corporation
- GE Healthcare
- Celera Diagnostics LLC
- Decode Genetics Inc.
- Exact Sciences Corporation
- IBM Corporation
- Exagen Inc.
- Biogen